These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33989048)

  • 1. Oral Nanoemulsion of Fenofibrate: Formulation, Characterization, and
    Gulati N; Kumar Chellappan D; Tambuwala M; A A Aljabali A; Prasher P; Kumar Singh S; Anand K; Sharma A; Kumar Jha N; Gupta G; Dua K; Dureja H
    Assay Drug Dev Technol; 2021; 19(4):246-261. PubMed ID: 33989048
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel electrosprayed nanospherules for enhanced aqueous solubility and oral bioavailability of poorly water-soluble fenofibrate.
    Yousaf AM; Mustapha O; Kim DW; Kim DS; Kim KS; Jin SG; Yong CS; Youn YS; Oh YK; Kim JO; Choi HG
    Int J Nanomedicine; 2016; 11():213-21. PubMed ID: 26834471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.
    Jia Z; Lin P; Xiang Y; Wang X; Wang J; Zhang X; Zhang Q
    Eur J Pharm Biopharm; 2011 Sep; 79(1):126-34. PubMed ID: 21658449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing the Solubility of Fenofibrate by Nanocrystal Formation and Encapsulation.
    Kumar R; Siril PF
    AAPS PharmSciTech; 2018 Jan; 19(1):284-292. PubMed ID: 28702816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
    Ige PP; Baria RK; Gattani SG
    Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.
    Mohsin K; Alamri R; Ahmad A; Raish M; Alanazi FK; Hussain MD
    Int J Nanomedicine; 2016; 11():2829-38. PubMed ID: 27366063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and delivery of improved amorphous fenofibrate solid dispersions prepared by thin film freezing.
    Zhang M; Li H; Lang B; O'Donnell K; Zhang H; Wang Z; Dong Y; Wu C; Williams RO
    Eur J Pharm Biopharm; 2012 Nov; 82(3):534-44. PubMed ID: 22974985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved dissolution rate and bioavailability of fenofibrate pellets prepared by wet-milled-drug layering.
    Wang P; Luo Q; Miao Y; Ying L; He H; Cai C; Tang X
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1344-53. PubMed ID: 22283480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of a self-microemulsifying drug delivery system for the poorly soluble drug fenofibrate.
    Cho YD; Park YJ
    Arch Pharm Res; 2014 Feb; 37(2):193-203. PubMed ID: 23754165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.
    Yousaf AM; Kim DW; Oh YK; Yong CS; Kim JO; Choi HG
    Int J Nanomedicine; 2015; 10():1819-30. PubMed ID: 25784807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of fenofibrate microemulsion for improved bioavailability.
    Hu L; Wu H; Niu F; Yan C; Yang X; Jia Y
    Int J Pharm; 2011 Nov; 420(2):251-5. PubMed ID: 21907776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.
    Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J
    Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement.
    Tran TH; Ramasamy T; Truong DH; Choi HG; Yong CS; Kim JO
    AAPS PharmSciTech; 2014 Dec; 15(6):1509-15. PubMed ID: 25035071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of oral bioavailability of fenofibrate by solid self-microemulsifying drug delivery systems.
    Kim GG; Poudel BK; Marasini N; Lee DW; Hiep TT; Yang KY; Kim JO; Yong CS; Choi HG
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1431-8. PubMed ID: 23046292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing in vitro dissolution and in vivo bioavailability of fenofibrate by solid self-emulsifying matrix combined with SBA-15 mesoporous silica.
    Quan G; Wu Q; Zhang X; Zhan Z; Zhou C; Chen B; Zhang Z; Li G; Pan X; Wu C
    Colloids Surf B Biointerfaces; 2016 May; 141():476-482. PubMed ID: 26896653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro and in vivo evaluation of fenofibrate with a self- microemulsifying formulation.
    Xiumin LI; Man GE; Minzi LU; Yinghua J; Dongqin Q
    Curr Drug Deliv; 2015; 12(3):308-13. PubMed ID: 26054534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of lipid matrix particles for fenofibrate: effect of polymorphism of glycerol monostearate on drug incorporation and release.
    Xia D; Cui F; Gan Y; Mu H; Yang M
    J Pharm Sci; 2014 Feb; 103(2):697-705. PubMed ID: 24375427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: a comparison of spray drying versus solvent impregnation methods.
    Hong S; Shen S; Tan DC; Ng WK; Liu X; Chia LS; Irwan AW; Tan R; Nowak SA; Marsh K; Gokhale R
    Drug Deliv; 2016; 23(1):316-27. PubMed ID: 24853963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of a fenofibrate-hydroxypropyl-beta-cyclodextrin system prepared by a co-grinding method.
    Gu FG; Wang Y; Meng GD; Han HB; Wu CZ
    Pharmazie; 2012 Feb; 67(2):143-6. PubMed ID: 22512084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxide.
    Sanganwar GP; Gupta RB
    Int J Pharm; 2008 Aug; 360(1-2):213-8. PubMed ID: 18550302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.